- J&J/Janssen gain 1st US approval in MDR-TB with Sirturo
- US FDA reviewers: Janssen's MDR-TB drug bedaquiline safe, effective
- Asia Beat: Indonesia sows new seeds in old furrow
- FDA panel backs Janssen's bedaquiline in MDR-TB, but with tight controls
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.